|
EP3697445A1
|
|
Transdermal formulation for delivery of hydrophobic compounds and process for the preparation thereof
|
|
CA3024205A1
|
|
Transdermal formulations for delivery of celecoxib and its use in the treatment of celecoxib-responsive diseases and conditions
|
|
CA2997842A1
|
|
Transdermal formulations for delivery of propionic and acetic acid nsaids, and their use in the treatment of nsaid-responsive diseases and conditions
|
|
US2018243212A1
|
|
Transdermal formulations for delivery of doxycycline, and their use in the treatment of doxycycline-responsive diseases and conditions
|
|
CA2995605A1
|
|
Transdermal formulations for delivery of berberine compounds, and their use in the treatment of berberine-responsive diseases and conditions
|
|
CA2994331A1
|
|
Transdermal formulations for delivery of capsaicinoids
|
